Email address
[email protected]Contact number
+506 8894 4465Share profile
Associates to watch
Provided by Ricardo Rodríguez
Director attorney of the firm in charge of the department of Intellectual Property of CENTRAL LAW in Costa Rica.
His practice is focused on Intellectual Property, New Technologies, Corporate Law, Unfair Competition and Consumer Protection, advising clients in their trademark portfolio, strategic management of IP assets and compliance with regard to IT and e-commerce matters.
He holds a law degree and a specialty in notary law from the Universidad Escuela Libre de Derecho and a LL.M in IP & IT from the Universidad Autónoma de Madrid, Spain.
Active member of the Costa Rican Bar Association, the sub-commission of IP matters in AmCham, member of AMPI-UAM University of Madrid, INTA Young Practitioners Sub-Committee (2018-2020) and Costa Rican Association for Intellectual Property Practitioners.
Distinguished by the Latin American Corporate Counsel guide LACCA APPROVED (2019 2020) as one of the leading lawyers in IP.
Current President of the Board of Directors of the Association of Intellectual Property Professionals of Costa Rica (APPICR) (2022 – 2024).
He is an author of articles for the Central American Magazine “The Lawyer”, regarding New Technologies.
Spanish and English
Costa Rica
Provided by Chambers
Associate-to-watch Ricardo Rodríguez leads the intellectual property department at CENTRAL LAW. He assists clients with the transfer of IP in the context of corporate restructuring and acquisitions, and trade mark portfolio management.
Provided by Chambers
Ricardo Rodríguez is a very capable lawyer with vast knowledge that is really helpful. He provides quick and concise answers, resolving all our queries.
Ricardo Rodríguez is a very capable lawyer with vast knowledge that is really helpful. He provides quick and concise answers, resolving all our queries.
Provided by CENTRAL LAW
Agriculture and Agribusiness
Art and Entertainment
Technology, Media and Telecoms (TMT)
Financial Services
Health and Life Sciences
